Rio Tinto Group - RIO.AX

RIO.AX Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
RIO.AX	-1.3	0.2	0.7	-0.4	3.7	-7.7	9.3	11.1	107.5	1314.9
S&P 500	0.3	1.8	2.2	5.3	9.8	25.5	38.4	83.5	197.4	34458.0

Compare RIO.AX with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	RIO.AX
name	Rio Tinto Group
price	118
changes percentage	-1.346
change	-1.61
day low	117.5
day high	119.18
year high	136.82
year low	105.11
market cap	167348134422
price avg 50	118.1368
price avg 200	119.7605
exchange	ASX
volume	861654
avg volume	988596
open	118.3
previous close	119.61
eps	10.63
pe	11.1
earnings announcement	2025-02-19T18:00:00.000+0000
shares outstanding	1418204529
timestamp	2025-01-23 05:10:04

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 45.0%

Overall Quarterly Financial Health: 50.3%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
revenue	54041000000	55554000000	-2.72
gross profit	17298000000	21299000000	-18.78
gross profit ratio	0.32	0.38	-16.51
research and development expenses	245000000	76000000	222.37
operating expenses	2475000000	2294000000	7.89
interest income	536000000	343000000	56.27
interest expense	1957000000	1865000000	4.93
ebitda	21076000000	22353000000	-5.71
ebitdaratio	0.39	0.4	-3.07
operating income	14823000000	17945000000	-17.40
operating income ratio	0.27	0.32	-15.08
net income	10058000000	12420000000	-19.02
net income ratio	0.19	0.22	-16.75
eps	6.17	7.67	-19.56

Overall Score of Annual Income Statement

0.0 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Revenue Growth: revenue decreased to 54,041 million in 2023 from 55,554 million in 2022 representing a change of -2.72%. This indicates a sales shrinking, which is a negative sign for the company.

  Gross Profit: Gross Profit decreased to 17,298 million in 2023 from 21,299 million in 2022 representing a change of -18.78%. This indicates a sales profitability decline, which is a negative sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses decreased to 245 million in 2023 from 76 million in 2022 representing a change of 222.37%. This shows that the company decreased investment in innovation and product development, which is not a good sign for long-term growth.

  Operating Expenses: Operating Expenses increased to 2,475 million in 2023 from 2,294 million in 2022 representing a change of 7.89%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to 21,076 million in 2023 from 22,353 million in 2022 representing a change of -5.71%. The decrease in EBITDA indicates declined operational efficiency and profitability.

  Operating Income: Operating income decreased to 14,823 million in 2023 from 17,945 million in 2022 representing a change of -17.4%. The decrease in operating income indicates worse operational performance and decreased profitability.

  Net Income: Net income decreased to 10,058 million in 2023 from 12,420 million in 2022 representing a change of -19.02%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 6.17 in 2023 from 6.17 in 2022 representing a change of -19.56%. This indicates that the company's earnings are decreasing and it is becoming less profitable on a per-share basis.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2024Q2	2023Q4	Q/Q change %
0000000000
revenue	26802000000	27374000000	-2.09
gross profit	8706000000	8166000000	6.61
gross profit ratio	0.32	0.3	8.89
research and development expenses	0	245000000	-100.00
operating expenses	447000000	626000000	-28.59
interest income	109000000	685000000	-84.09
interest expense	0	0	NaN
ebitda	10539000000	9106000000	15.74
ebitdaratio	0.39	0.33	18.21
operating income	8259000000	7005000000	17.90
operating income ratio	0.31	0.26	20.42
net income	5808000000	4941000000	17.55
net income ratio	0.22	0.18	20.06
eps	3.56	3.03	17.49

Overall Score of Quarterly Income Statement

0.62 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Revenue Growth: revenue decreased to 26,802 million in 2024Q2 from 27,374 million in 2023Q4 representing a change of -2.09%. This indicates a sales shrinking, which is a negative sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses decreased to 0 million in 2024Q2 from 245 million in 2023Q4 representing a change of -100.0%. This shows that the company decreased investment in innovation and product development, which is not a good sign for long-term growth.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to 10,539 million in 2024Q2 from 9,106 million in 2023Q4 representing a change of 15.74%. The decrease in EBITDA indicates declined operational efficiency and profitability.

• 📈 Positive Indicators

  Gross Profit: Gross Profit increased to 8,706 million in 2024Q2 from 8,166 million in 2023Q4 representing a change of 6.61%. This indicates a sales profitability growth, which is a positive sign for the company.

  Operating Expenses: Operating Expenses decreased to 447 million in 2024Q2 from 626 million in 2023Q4 representing a change of -28.59%. The decrease in operating expenses can be attributed to various factors such as improved profitability, cost optimization and financial stability, lower operating expenses can be positive indicators.

  Operating Income: Operating income increased to 8,259 million in 2024Q2 from 7,005 million in 2023Q4 representing a change of 17.9%. The increase in operating income indicates better operational performance and increased profitability.

  Net Income: Net income increased to 5,808 million in 2024Q2 from 4,941 million in 2023Q4 representing a change of 17.55%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 3.56 in 2024Q2 from 3.56 in 2023Q4 representing a change of 17.49%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
total assets	103549000000	96744000000	7.03
total liabilities	47208000000	44470000000	6.16
total equity	56341000000	52274000000	7.78
cash and cash equivalents	8698000000	6775000000	28.38
short term investments	1078000000	2132000000	-49.44
long term investments	4787000000	3663000000	30.69
total current assets	21510000000	18973000000	13.37
total non current assets	82039000000	72868000000	12.59
total current liabilities	12743000000	11603000000	9.83
total non current liabilities	34465000000	10148000000	239.62
common stock	3584000000	3537000000	1.33
retained earnings	38350000000	34511000000	11.12
total debt	14352000000	12271000000	16.96

Overall Score of Annual Balance Sheet

0.6 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 103,549 million in 2023 from 96,744 million in 2022 representing a change of 7.03%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 56,341 million in 2023 from 52,274 million in 2022 representing a change of 7.78%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 8,698 million in 2023 from 6,775 million in 2022 representing a change of 28.38%. This indicates an increase in available liquid assets.

  Total Current Assets: Total Current Assets increased to 21,510 million in 2023 from 18,973 million in 2022 representing a change of 13.37%. This indicates a better liquidity position.

  Common Stock: Common Stock increased to 3,584 in 2023 from 3,537 in 2022 representing a change of 1.33%. This indicates an increase in ownership interest.

  Retained Earnings: Retained Earnings increased to 38,350 million in 2023 from 34,511 million in 2022 representing a change of 11.12%. This indicates an accumulated profits.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 47,208 million in 2023 from 44,470 million in 2022 representing a change of 6.16%. This indicates an increase in overall liabilities.

  Short Term Investments: Short Term Investments decreased to 1,078 million in 2023 from 2,132 million in 2022 representing a change of -49.44%. This indicates a decrease in short-term investment holdings.

  Total Current Liabilities: Total Current Liabilities increased to 12,743 million in 2023 from 11,603 million in 2022 representing a change of 9.83%. This indicates a higher short-term debt burden.

  Total Debt: Total Debt increased to 14,352 million in 2023 from 12,271 million in 2022 representing a change of 16.96%. This indicates an increase in overall debt burden.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2024Q2	2023Q4	Q/Q change %
0000000000
total assets	101887000000	103549000000	-1.61
total liabilities	44723000000	47208000000	-5.26
total equity	57164000000	56341000000	1.46
cash and cash equivalents	9256000000	8698000000	6.42
short term investments	569000000	1078000000	-47.22
long term investments	5026000000	4787000000	4.99
total current assets	20422000000	21510000000	-5.06
total non current assets	81465000000	82039000000	-0.70
total current liabilities	12034000000	12743000000	-5.56
total non current liabilities	32689000000	34465000000	-5.15
common stock	3485000000	3584000000	-2.76
retained earnings	40149000000	38350000000	4.69
total debt	14299000000	14352000000	-0.37

Overall Score of Quarterly Balance Sheet

0.6 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Total Assets: Total Assets decreased to 101,887 million in 2024Q2 from 103,549 million in 2023Q4 representing a change of -1.61%. Suggesting a decrease in asset holdings.

  Short Term Investments: Short Term Investments decreased to 569 million in 2024Q2 from 1,078 million in 2023Q4 representing a change of -47.22%. This indicates a decrease in short-term investment holdings.

  Total Current Assets: Total Current Assets decreased to 20,422 million in 2024Q2 from 21,510 million in 2023Q4 representing a change of -5.06%. This indicates a worsen liquidity position.

  Common Stock: Common Stock decreased to 3,485 in 2024Q2 from 3,584 in 2023Q4 representing a change of -2.76%. This indicates a decrease in ownership interest.

• 📈 Positive Indicators

  Total Liabilities: Total Liabilities decreased to 44,723 million in 2024Q2 from 47,208 million in 2023Q4 representing a change of -5.26%. This indicates a decrease in overall liabilities.

  Total Equity: Total Equity increased to 57,164 million in 2024Q2 from 56,341 million in 2023Q4 representing a change of 1.46%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 9,256 million in 2024Q2 from 8,698 million in 2023Q4 representing a change of 6.42%. This indicates an increase in available liquid assets.

  Total Current Liabilities: Total Current Liabilities decreased to 12,034 million in 2024Q2 from 12,743 million in 2023Q4 representing a change of -5.56%. This indicates a lower short-term debt burden.

  Retained Earnings: Retained Earnings increased to 40,149 million in 2024Q2 from 38,350 million in 2023Q4 representing a change of 4.69%. This indicates an accumulated profits.

  Total Debt: Total Debt decreased to 14,299 million in 2024Q2 from 14,352 million in 2023Q4 representing a change of -0.37%. This indicates a reduction in overall debt burden.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
net change in cash	2898000000	-6031000000	148.05
operating cash flow	15160000000	16134000000	-6.04
free cash flow	8074000000	9384000000	-13.96
capital expenditure	-7086000000	-6750000000	-4.98
depreciation and amortization	5334000000	4764000000	11.96
deferred income tax	3832000000	5586000000	-31.40
stock based compensation	0	122000000	-100.00
accounts payables	418000000	1242000000	-66.34
inventory	-422000000	-1185000000	64.39
acquisitions net	-834000000	-845000000	1.30
investments in property plant and equipment	-7086000000	-6750000000	-4.98
net cash used for investing activites	-6962000000	-6707000000	-3.80
debt repayment	1097000000	-843000000	230.13
common stock issued	0	0	NaN
common stock repurchased	0	0	NaN
dividends paid	-6470000000	-11727000000	44.83
net cash used provided by financing activities	-5277000000	-15473000000	65.90
cash at end of period	9672000000	6774000000	42.78
accounts receivables	-418000000	20000000	-2190.00
cash at beginning of period	6774000000	12805000000	-47.10

Overall Score of Annual Cashflow Statement

0.75 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 2,898 million in 2023 from -6,031 million in 2022 representing a change of 148.05%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Capital Expenditure: Capital Expenditure decreased to -7,086 million in 2023 from -6,750 million in 2022 representing a change of -4.98%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.

  Stock-Based Compensation: Stock-Based Compensation decreased to 0 million in 2023 from 122 million in 2022 representing a change of -100.0%. This indicates decreased expenses, which is generally considered a positive sign from a financial perspective.

  Accounts Payables: The absolute value of Accounts Payables decreased to 418 million in 2023 from 1,242 million in 2022 representing a change of -66.34%. This indicates that the company has reduced its outstanding obligations to its suppliers.

  Accounts Receivables: Accounts Receivables decreased to -418 million in 2023 from 20 million in 2022 representing a change of -2190.0%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.

  Dividends Paid: Dividends Paid increased to -6,470 million in 2023 from -11,727 million in 2022 representing a change of 44.83%. This indicates a stronger financial position, more confidence in future prospects, and a better commitment to returning value to shareholders.

• 📉 Negative Indicators

  Operating Cash Flow: Operating Cash Flow decreased to 15,160 million in 2023 from 16,134 million in 2022 representing a change of -6.04%. This indicates that the company generated less cash from its core business operations.

  Free Cash Flow: Free Cash Flow decreased to 8,074 million in 2023 from 9,384 million in 2022 representing a change of -13.96%. This indicates a decrease in cash generated after accounting for capital expenditures.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024Q2	2023Q4	Q/Q change %
0000000000
operating cash flow	7056000000	8185000000	-13.79
free cash flow	3038000000	4100000000	-25.90
capital expenditure	-4018000000	-4085000000	1.64
depreciation and amortization	2821000000	2494000000	13.11
deferred income tax	0	0	NaN
stock based compensation	0	144000000	-100.00
accounts receivables	107000000	-412000000	125.97
accounts payables	0	0	NaN
inventory	-41000000	-129000000	68.22
acquisitions net	0	-819000000	100.00
investments in property plant and equipment	-4018000000	-4085000000	1.64
net cash used for investing activites	-3544000000	-4726000000	25.01
debt repayment	-226000000	0	NaN
common stock issued	0	0	NaN
common stock repurchased	0	0	NaN
dividends paid	-4121000000	-2779000000	-48.29
net cash used provided by financing activities	-3901000000	-2997000000	-30.16
net change in cash	9253000000	498000000	1758.03
cash at end of period	9253000000	9672000000	-4.33
cash at beginning of period	0	9174000000	-100.00

Overall Score of Quarterly Cashflow Statement

0.29 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 9,253 million in 2024Q2 from 498 million in 2023Q4 representing a change of 1758.03%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Stock-Based Compensation: Stock-Based Compensation decreased to 0 million in 2024Q2 from 144 million in 2023Q4 representing a change of -100.0%. This indicates decreased expenses, which is generally considered a positive sign from a financial perspective.

• 📉 Negative Indicators

  Operating Cash Flow: Operating Cash Flow decreased to 7,056 million in 2024Q2 from 8,185 million in 2023Q4 representing a change of -13.79%. This indicates that the company generated less cash from its core business operations.

  Free Cash Flow: Free Cash Flow decreased to 3,038 million in 2024Q2 from 4,100 million in 2023Q4 representing a change of -25.9%. This indicates a decrease in cash generated after accounting for capital expenditures.

  Capital Expenditure: Capital Expenditure increased to -4,018 million in 2024Q2 from -4,085 million in 2023Q4 representing a change of 1.64%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

  Accounts Receivables: Accounts Receivables increased to 107 in 2024Q2 from -412 million in 2023Q4 representing a change of 125.97%. This suggests that the company is less capable of collecting payments from its customers.

  Dividends Paid: Dividends Paid decreased to -4,121 million in 2024Q2 from -2,779 million in 2023Q4 representing a change of -48.29%. This indicates a weaker financial position, less confidence in future prospects, and a reluctance to return value to shareholders.

Earnings Transcripts ⓘ

We save you time by utilizing Generative AI to summarize earnings transcripts. Our summaries provide a clear insight into the company's current performance, future outlook, and overall sentiment expressed during the call. Click on below links to explore more.

Note: The years mentioned below are fiscal years in accounting.

Q2 2024 Earnings call transcript
Q4 2023 Earnings call transcript
Q1 2023 Earnings call transcript
Q4 2022 Earnings call transcript
Q1 2022 Earnings call transcript
Q4 2021 Earnings call transcript
Q1 2021 Earnings call transcript
Q4 2020 Earnings call transcript

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2023-12-31	2022-12-31	Y/Y change %
FY
calendar year	2023	2022	NaN
revenue per share	33.12	33.3	-0.54
net income per share	6.17	7.43	-17.01
operating cash flow per share	9.29	9.67	-3.93
free cash flow per share	4.95	5.63	-12.03
cash per share	5.99	5.36	11.87
book value per share	34.53	31.34	10.20
tangible book value per share	31.36	28.66	9.41
shareholders equity per share	33.46	30.08	11.23
interest debt per share	10.0	8.47	18.05
market cap	121330086315.61	116886413214.11	3.80
enterprise value	126984086315.61	122382413214.11	3.76
pe ratio	12.06	9.43	27.89
price to sales ratio	2.25	2.1	6.71
pocfratio	8.0	7.24	10.47
pfcf ratio	15.03	12.46	20.64
pb ratio	2.22	2.33	-4.59
ptb ratio	2.22	2.33	-4.59
ev to sales	2.35	2.2	6.67
enterprise value over ebitda	6.03	4.79	25.72
ev to operating cash flow	8.38	7.59	10.43
ev to free cash flow	15.73	13.04	20.60
earnings yield	0.08	0.11	-21.81
free cash flow yield	0.07	0.08	-17.11
debt to equity	0.26	0.24	7.51
debt to assets	0.14	0.13	9.27
net debt to ebitda	0.27	0.22	24.65
current ratio	1.69	1.64	3.23
interest coverage	7.57	10.75	-29.55
income quality	1.52	1.23	23.45
dividend yield	0.05	0.1	-46.85
payout ratio	0.64	0.95	-32.03
sales general and administrative to revenue	0.1	0.08	27.96
research and ddevelopement to revenue	0.0	0.0	231.39
intangibles to total assets	0.05	0.05	8.37
capex to operating cash flow	0.47	0.42	11.72
capex to revenue	0.13	0.12	7.92
capex to depreciation	1.33	1.35	-1.40
stock based compensation to revenue	0	0.0	-100.00
graham number	68.13	70.91	-3.92
roic	0.12	0.16	-28.05
return on tangible assets	0.1	0.13	-23.86
graham net net	-20.9	-18.46	-13.23
working capital	8767000000	7370000000	18.96
tangible asset value	51155000000	47803000000	7.01
net current asset value	-25698000000	-25497000000	-0.79
invested capital	82400000000	76575000000	7.61
average receivables	1089500000	2210000000	-50.70
average payables	3267000000	3339500000	-2.17
average inventory	6436000000	5824500000	10.50
days sales outstanding	0	14.32	-100.00
days payables outstanding	55.07	56.06	-1.77
days of inventory on hand	112.32	106.55	5.42
receivables turnover	0	25.5	-100.00
payables turnover	6.63	6.51	1.80
inventory turnover	3.25	3.43	-5.14
roe	0.18	0.25	-25.39
capex per share	4.34	4.05	7.33

• Neutral

  ROE: Return on Equity (ROE) decreased to 0.18 on 2023-12-31 from 0.25 on 2022-12-31, representing a change of -25.39%. However, ROE is >= 15%, suggesting that the company has been generating high returns for its shareholders still.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio increased to 0.26 on 2023-12-31 from 0.24 on 2022-12-31, representing a change of 7.51%. The debt-to-equity ratio has been increasing, indicating that the company has been relying more on debt financing. Higher leverage may increase financial risk. However, a ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 12.06 on 2023-12-31 from 9.43 on 2022-12-31, representing a change of 27.89%. Indicating an increase in the relative valuation of the company's stock.

  Current Ratio: Current Ratio increased to 1.69 on 2023-12-31 from 1.64 on 2022-12-31, representing a change of 3.23%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Also, it's above 1, indicating the ability to cover short-term obligations.

• Quarterly Financial Ratios

	2024-06-30 Q2	2023-12-31 Q4	Q/Q change %
RIO.AX
calendar year	2024	2023	NaN
revenue per share	16.42	16.77	-2.06
net income per share	3.56	3.03	17.58
operating cash flow per share	4.32	5.01	-13.77
free cash flow per share	1.86	2.51	-25.88
cash per share	6.02	5.99	0.53
book value per share	35.02	34.51	1.49
tangible book value per share	32.23	32.54	-0.97
shareholders equity per share	33.85	33.43	1.25
interest debt per share	8.56	8.79	-2.66
market cap	108139700458.81	121428993584.29	-10.94
enterprise value	112850700458.81	127082993584.29	-11.20
pe ratio	4.65	6.14	-24.24
price to sales ratio	4.03	4.44	-9.04
pocfratio	15.33	14.84	3.31
pfcf ratio	35.6	29.62	20.19
pb ratio	1.96	2.22	-12.02
ptb ratio	1.96	2.22	-12.02
ev to sales	4.21	4.64	-9.30
enterprise value over ebitda	10.71	13.96	-23.27
ev to operating cash flow	15.99	15.53	3.01
ev to free cash flow	37.15	31.0	19.84
earnings yield	0.05	0.04	31.99
free cash flow yield	0.03	0.03	-16.80
debt to equity	0.25	0.26	-3.86
debt to assets	0.14	0.14	-1.10
net debt to ebitda	0.45	0.62	-28.01
current ratio	1.7	1.69	0.54
interest coverage	0	0	NaN
income quality	1.21	1.66	-26.66
dividend yield	0.04	0.02	66.51
payout ratio	0.71	0.56	26.15
sales general and administrative to revenue	0	0	NaN
research and ddevelopement to revenue	0	0.01	-100.00
intangibles to total assets	0.04	0.03	44.44
capex to operating cash flow	0.57	0.5	14.10
capex to revenue	0.15	0.15	0.46
capex to depreciation	1.42	1.64	-13.04
stock based compensation to revenue	0	0.01	-100.00
graham number	52.05	47.71	9.11
roic	0.06	0.06	11.14
return on tangible assets	0.06	0.05	21.19
graham net net	-17.6	-19.76	10.92
working capital	8388000000	8767000000	-4.32
tangible asset value	52606000000	53134000000	-0.99
net current asset value	-24301000000	-25698000000	5.44
invested capital	79525000000	80421000000	-1.11
average receivables	None	None	NaN
average payables	None	None	NaN
average inventory	None	None	NaN
days sales outstanding	13.04	8.09	61.19
days payables outstanding	38.24	15.3	149.97
days of inventory on hand	32.41	31.2	3.88
receivables turnover	6.9	11.12	-37.96
payables turnover	2.35	5.88	-60.00
inventory turnover	2.78	2.88	-3.74
roe	0.11	0.09	16.13
capex per share	2.46	2.5	-1.61

• ROE:

• Negative

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to 4.65 on 2024-06-30 Q2 from 6.14 on 2023-12-31 Q4, representing a change of -24.24%. Indicating a decrease in the relative valuation of the company's stock.

• Positive

  Current Ratio: Current Ratio increased to 1.70 on 2024-06-30 Q2 from 1.69 on 2023-12-31 Q4, representing a change of 0.54%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Also, it's above 1, indicating the ability to cover short-term obligations.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.25 on 2024-06-30 Q2 from 0.26 on 2023-12-31 Q4, representing a change of -3.86%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

Positive Sentiment: Discounted Cash Flow value is 251.02 which is higher than current price 118, indicates the company may be undervalued.